235 related articles for article (PubMed ID: 35671687)
1. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
[TBL] [Abstract][Full Text] [Related]
2. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
[TBL] [Abstract][Full Text] [Related]
3. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
[TBL] [Abstract][Full Text] [Related]
4. High willingness to use rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Yedinak JL; Buxton JA; Lysyshyn M; Bernstein E; Rich JD; Green TC; Hadland SE; Marshall BDL
Harm Reduct J; 2018 Feb; 15(1):7. PubMed ID: 29422052
[TBL] [Abstract][Full Text] [Related]
5. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
[TBL] [Abstract][Full Text] [Related]
6. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
[TBL] [Abstract][Full Text] [Related]
8. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
[TBL] [Abstract][Full Text] [Related]
9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
10. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
11. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
12. Use of rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL
Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005
[TBL] [Abstract][Full Text] [Related]
13. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
14. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
[TBL] [Abstract][Full Text] [Related]
15. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
[TBL] [Abstract][Full Text] [Related]
16. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
19. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.
Moon KJ; Whitehead HD; Trinh A; Hasenstab KA; Hayes KL; Stanley D; Carter B; Barclay R; Lieberman M; Nawaz S
Harm Reduct J; 2024 Jan; 21(1):11. PubMed ID: 38218980
[TBL] [Abstract][Full Text] [Related]
20. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]